Symptomatic heart failure (HF) patients despite optimal medical therapy and advances such as invasive hemodynamic monitoring remain challenging to manage. While cardiac resynchronization therapy remains a highly effective therapy for a subset of HF patients with wide QRS, a majority of symptomatic HF patients are poor candidates for such. Recently, cardiac contractility modulation, neuromodulation based on carotid baroreceptor stimulation, and phrenic nerve stimulation have been approved by the US Food and Drug Administration and are emerging as therapeutic options for symptomatic HF patients. This state-of-the-art review examines the role of these evolving electrical therapies in advanced HF.
Evolving Cardiac Electrical Therapies for Advanced Heart Failure Patients
Zain I. Sharif,V. Galand,W. Hucker,Jagmeet P. Singh
Published 2021 in Circulation: Arrhythmia and Electrophysiology
ABSTRACT
PUBLICATION RECORD
- Publication year
2021
- Venue
Circulation: Arrhythmia and Electrophysiology
- Publication date
2021-04-01
- Fields of study
Medicine, Engineering
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-79 of 79 references · Page 1 of 1
CITED BY
Showing 1-9 of 9 citing papers · Page 1 of 1